Product logins

Find logins to all Clarivate products below.


Blog: Biopharma

Here you will find relevant articles and insight into all Clarivate related products and news.

Five lessons learned deploying agentic AI in the life sciences Five lessons learned deploying agentic AI in the life sciences
Blog April 30, 2026
Five lessons learned deploying agentic AI in the life sciences
AI
Target selection and safety assessment: Navigating early decisions that shape drug development Target selection and safety assessment: Navigating early decisions that shape drug development
Blog March 27, 2026
Target selection and safety assessment: Navigating early decisions that shape drug development
Development Pharma Regulatory
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
Blog March 26, 2026
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
GLP-1 Metabolic
Why longevity might be biopharma's next big thing: The science and business converge Why longevity might be biopharma's next big thing: The science and business converge
Blog March 2, 2026
Why longevity might be biopharma's next big thing: The science and business converge
Gerontology
Why ease of administration in new drugs sometimes draws a yawn from payers Why ease of administration in new drugs sometimes draws a yawn from payers
Blog February 26, 2026
Why ease of administration in new drugs sometimes draws a yawn from payers
Biopharma Biotech Clinical trials
The path forward: What comes after a CRL? The path forward: What comes after a CRL?
Blog February 24, 2026
The path forward: What comes after a CRL?
Biopharma Biotech Clinical trials
Relacorilant:  when evidence meets the established evidence bar Relacorilant:  when evidence meets the established evidence bar
Blog February 24, 2026
Relacorilant: when evidence meets the established evidence bar
FDA Regulatory Safety
Tolebrutinib: when safety concerns override efficacy signals Tolebrutinib: when safety concerns override efficacy signals
Blog February 24, 2026
Tolebrutinib: when safety concerns override efficacy signals
Biopharma Biotech Clinical trials

Biopharma

How retailers and “payviders” are disrupting U.S. healthcare in 2024 How retailers and “payviders” are disrupting U.S. healthcare in 2024
Blog April 19, 2024
How retailers and “payviders” are disrupting U.S. healthcare in 2024
Real world data reveal how diseases manifest in diverse populations Real world data reveal how diseases manifest in diverse populations
Blog April 4, 2024
Real world data reveal how diseases manifest in diverse populations
Navigating Joint Clinical Assessment and the role of RWE in the new process Navigating Joint Clinical Assessment and the role of RWE in the new process
Blog March 29, 2024
Navigating Joint Clinical Assessment and the role of RWE in the new process
Rebates are likely driving U.S. payer coverage of GLP-1 agonists Rebates are likely driving U.S. payer coverage of GLP-1 agonists
Blog March 19, 2024
Rebates are likely driving U.S. payer coverage of GLP-1 agonists
Getting ahead of regulatory changes around PFAS in pharmaceutical packaging Getting ahead of regulatory changes around PFAS in pharmaceutical packaging
Blog March 14, 2024
Getting ahead of regulatory changes around PFAS in pharmaceutical packaging
Future-proofing drug R&D to ensure a successful commercial launch Future-proofing drug R&D to ensure a successful commercial launch
Blog March 12, 2024
Future-proofing drug R&D to ensure a successful commercial launch
Unleashing the power of computational tools in rare disease Unleashing the power of computational tools in rare disease
Blog February 28, 2024
Unleashing the power of computational tools in rare disease
Unlocking the potential of AI and machine learning for the life sciences Unlocking the potential of AI and machine learning for the life sciences
Blog February 5, 2024
Unlocking the potential of AI and machine learning for the life sciences
Pharma R&D productivity dips, but efficiency gains give hope Pharma R&D productivity dips, but efficiency gains give hope
Blog January 23, 2024
Pharma R&D productivity dips, but efficiency gains give hope
Five U.S. market access trends to watch in 2024 Five U.S. market access trends to watch in 2024
Blog December 15, 2023
Five U.S. market access trends to watch in 2024